Joshua B. Cohen, Co-CEO: Amylyx Pharmaceuticals AMLX Planned sale · Filed 03/02

Trade details

Type: Planned sale notice
Stock: Amylyx Pharmaceuticals AMLX
Person: Joshua B. CohenCo-CEO
Planned sale date: 26/03/02
Filed: 26/03/02

More to sell after $2.2M in 3 months

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Joshua B. Cohen's recent trades

Joshua B. CohenCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$980.5K
30,464 sh
$980.5K
Filed 09/11
Traded 09/10
Joshua B. CohenCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$424K
29,282 sh
$424K
Filed 03/04
Traded 03/02
Joshua B. CohenCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$227.5K
15,500 sh
$227.5K
Filed 02/04
Traded 02/02
Joshua B. CohenCo-CEO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02
Joshua B. CohenCo-CEO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$1.9M
136,193 sh
$1.9M
Filed 01/20
Traded 01/15